Anticancer Res
- HERNANDEZ-VALENCIA CG, Rodriguez-Martinez G, Carriles-Perez AM, Gonzalez-Perez D, et al
Antiproliferative and Antimigratory Activity of Poly-gallic Acid in Cancer Cell
Lines.
Anticancer Res. 2024;44:1201-1208.
BMC Cancer
- SHEN Z, Yao C, Bai Y, Wang Y, et al
Transversal approach via a bladder neck and prostate combined longitudinal
incision versus standard approach of robotic-assisted radical prostatectomy for
localized prostate cancer: a retrospective analysis.
BMC Cancer. 2024;24:313.
- CUI F, Qiu Y, Xu W, Zou C, et al
Pretreatment prostate-specific antigen density as a predictor of biochemical
recurrence in patients with prostate cancer: a meta-analysis.
BMC Cancer. 2024;24:305.
- MIYAZAWA Y, Koike H, Oka D, Kawamura H, et al
Comparison of sexual function after robot-assisted radical prostatectomy and
carbon-ion radiotherapy for Japanese prostate cancer patients using propensity
score matching.
BMC Cancer. 2024;24:300.
- FU Q, Luo L, Hong R, Zhou H, et al
Radiogenomic analysis of ultrasound phenotypic features coupled to proteomes
predicts metastatic risk in primary prostate cancer.
BMC Cancer. 2024;24:290.
- KHALIL MIM, Ashour A, Shaala RS, Allam RM, et al
Effect of health belief model-based educational intervention on prostate cancer
prevention; knowledge, practices, and intentions.
BMC Cancer. 2024;24:289.
BMC Urol
- YU C, Jingzhen Z, Luqiang Z, Xiaojuan Y, et al
Coping strategies mediate the relationship between fear of cancer recurrence and
quality of life in postoperative patients with prostate cancer: a multicentre
survey.
BMC Urol. 2024;24:49.
Br J Cancer
- GNANAPRAGASAM V
Shifting the paradigm in the management of early prostate cancer.
Br J Cancer. 2024 Mar 6. doi: 10.1038/s41416-024-02641.
Cancer
- BENADADA F, Saad F, Delouya G, Taussky D, et al
Charles Brenton Huggins: A historical review of the Nobel laureate's pioneering
discoveries.
Cancer. 2024;130:1019-1024.
Cancer Imaging
- YAZDANI E, Karamzadeh-Ziarati N, Cheshmi SS, Sadeghi M, et al
Automated segmentation of lesions and organs at risk on [(68)Ga]Ga-PSMA-11 PET/CT
images using self-supervised learning with Swin UNETR.
Cancer Imaging. 2024;24:30.
Cancer Lett
- RODRIGO-FAUS M, Vincelle-Nieto A, Vidal N, Puente J, et al
CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel
essential gene in prostate cancer metastasis.
Cancer Lett. 2024 Mar 1:216776. doi: 10.1016/j.canlet.2024.216776.
Discov Oncol
- WANG L, Zheng YB, Yin S, Li KP, et al
Causal relationship between gut microbiota and prostate cancer contributes to the
gut-prostate axis: insights from a Mendelian randomization study.
Discov Oncol. 2024;15:58.
Eur Urol
- GOLIJANIN B, Mega A, Golijanin D
Re: Ivo I. de Vos II, Sebastiaan Remmers, Renee Hogenhout, Monique J. Roobol,
ERSPC Rotterdam Study Group. Prostate Cancer Mortality Among Elderly Men After
Discontinuing Organised Screening: Long-term Results from the European Randomized
Study of Scr
Eur Urol. 2024 Feb 29:S0302-2838(24)00081-2. doi: 10.1016/j.eururo.2024.
Int J Cancer
- ZHANG Y, Stopsack KH, Song M, Mucci LA, et al
Healthy dietary patterns and risk of prostate cancer in men at high genetic risk.
Int J Cancer. 2024 Mar 1. doi: 10.1002/ijc.34898.
Int J Radiat Oncol Biol Phys
- PATEL KR, Rydzewski NR, Schott E, Cooley-Zgela T, et al
A Phase I Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent
Prostate Cancer After Brachytherapy.
Int J Radiat Oncol Biol Phys. 2024 Feb 28:S0360-3016(24)00323.
Int J Urol
- BLAS L, Shiota M, Tanegashima T, Kobayashi S, et al
Survival beyond cabazitaxel for metastatic castration-resistant prostate cancer.
Int J Urol. 2024 Mar 5. doi: 10.1111/iju.15449.
- KAWASE M, Kato D, Tobisawa Y, Iinuma K, et al
Efficacy and safety of combination neoadjuvant chemo-hormonal therapy and
robot-assisted radical prostatectomy for oligometastatic prostate cancer.
Int J Urol. 2024 Mar 7. doi: 10.1111/iju.15448.
- GOTO Y
Editorial Comment on Exploring androgen receptor signaling pathway in prostate
cancer: A path to new discoveries.
Int J Urol. 2024 Mar 8. doi: 10.1111/iju.15444.
J Clin Oncol
- HEISS BL, Chang E, Gao X, Truong T, et al
US Food and Drug Administration Approval Summary: Talazoparib in Combination With
Enzalutamide for Treatment of Patients With Homologous Recombination Repair
Gene-Mutated Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol. 2024 Mar 7:JCO2302182. doi: 10.1200/JCO.23.02182.
J Nucl Med
- HARTRAMPF PE, Huttmann T, Seitz AK, Kubler H, et al
Prognostic Performance of RECIP 1.0 Based on [(18)F]PSMA-1007 PET in Prostate
Cancer Patients Treated with [(177)Lu]Lu-PSMA I&T.
J Nucl Med. 2024 Mar 7:jnumed.123.266702. doi: 10.2967/jnumed.123.266702.
Oncogene
- ARRIAGA JM, Ronaldson-Bouchard K, Picech F, Nunes de Almeida F, et al
In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate
cancer bone metastasis.
Oncogene. 2024 Mar 7. doi: 10.1038/s41388-024-02995.
- LI J, Hong Z, Zhang J, Zheng S, et al
Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate
CRPC cell resistance to enzalutamide.
Oncogene. 2024;43:744-757.
Oncology
- SCHAULIN MS, Delouya G, Zwahlen D, Taussky D, et al
Tracing the Evolution of Prostate Brachytherapy in the 20th Century.
Oncology. 2024;102:283-290.
PLoS One
- TAKAKUSAGI Y, Koge H, Kano K, Shima S, et al
Five-year clinical outcomes of scanning carbon-ion radiotherapy for prostate
cancer.
PLoS One. 2024;19:e0290617.
- DARBA J, Ascanio M
Prostate cancer in Spain: A retrospective database analysis of hospital incidence
and the direct medical costs.
PLoS One. 2024;19:e0298764.
Prostate
- BRENNEN WN, Le Magnen C, Karkampouna S, Anselmino N, et al
Defining the challenges and opportunities for using patient-derived models in
prostate cancer research.
Prostate. 2024 Mar 7. doi: 10.1002/pros.24682.
Radiol Artif Intell
- HU L, Guo X, Zhou D, Wang Z, et al
Development and Validation of a Deep Learning Model to Reduce the Interference of
Rectal Artifacts in MRI-based Prostate Cancer Diagnosis.
Radiol Artif Intell. 2024 Mar 6:e230362. doi: 10.1148/ryai.230362.
Radiology
- GHAI S, Finelli A, Corr K, Lajkosz K, et al
MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate
Cancer: Final Results from a 2-year Phase II Clinical Trial.
Radiology. 2024;310:e231473.
- WOODRUM DA
Less Is More: MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk
Prostate Cancer.
Radiology. 2024;310:e240258.
Urol Int
- HU S, Xiong X, Qiu S, Li J, et al
Comparing efficacies of different exercises on androgen deprivation therapy
adverse effects in prostate cancer patients: a network meta-analysis.
Urol Int. 2024 Mar 2. doi: 10.1159/000538114.
Urology
- ALBERS P, Bennett J, Evans M, Martin ES, et al
Value of Incremental Biopsy Cores for Microultrasound Targeted Prostate Biopsies.
Urology. 2024;184:142-148.
- SHAH MS, Lallas CD
Editorial Commentary on Improving Racial Disparities in Prostate Cancer.
Urology. 2024 Feb 29:S0090-4295(24)00123-7. doi: 10.1016/j.urology.2024.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016